Visual hallucinations in Parkinson’s disease: spotlight on central cholinergic dysfunction

Control of goal-directed and stimulus-driven attention in the brain

Corbetta, M., & Shulman, G. L. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn755 · Cited by 12,881 · see citing works

Complex brain networks: graph theoretical analysis of structural and functional systems

Bullmore, E., & Sporns, O. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2575 · Cited by 11,820 · see citing works

The brain's default mode network

Raichle, M. E. (2015) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-071013-014030 · Cited by 3,904 · see citing works

Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030

Dorsey, E. R., Constantinescu, R., Thompson, J. P., Biglan, K., Holloway, R. G., Kieburtz, K. D., Marshall, F. J., Ravina, B. M., Schifitto, G., Siderowf, A. D., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000247740.47667.03 · Cited by 2,479 · see citing works

Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey

Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962 · see citing works

Parkinson's disease

Lees, A. J., Hardy, J., & Revesz, T. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60492-x · Cited by 1,956 · see citing works

Uncertainty, Neuromodulation, and Attention

Yu, A. J., & Dayan, P. (2005) · Neuron · doi:10.1016/j.neuron.2005.04.026 · Cited by 1,774 · see citing works

Mammalian nicotinic acetylcholine receptors: from structure to function

Albuquerque, E. X., Pereira, E. F. R., Alkondon, M., & Rogers, S. W. (2009) · Physiological Reviews · doi:10.1152/physrev.00015.2008 · Cited by 1,724 · see citing works

The role of acetylcholine in learning and memory

Hasselmo, M. E. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.09.002 · Cited by 1,693 · see citing works

Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior

Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404 · see citing works

Dimensionality reduction for large-scale neural recordings

Cunningham, J. P., & Yu, B. M. (2014) · Nature Neuroscience · doi:10.1038/nn.3776 · Cited by 1,219 · see citing works

Controllability of structural brain networks

Gu, S., Pasqualetti, F., Cieslak, M., Telesford, Q. K., Yu, A. B., Kahn, A. E., Medaglia, J. D., Vettel, J. M., Miller, M. B., Grafton, S. T., et al. (2015) · Nature Communications · doi:10.1038/ncomms9414 · Cited by 912 · see citing works

Efferent connections of the habenular nuclei in the rat

Herkenham, M. A., & Nauta, W. J. H. (1979) · The Journal of Comparative Neurology · doi:10.1002/cne.901870103 · Cited by 855 · see citing works

Parkinson's Disease and Parkinsonism: Neuropathology

Dickson, D. W. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009258 · Cited by 847 · see citing works

Predictors of Nursing Home Placement in Parkinson's Disease: A Population‐Based, Prospective Study

Aarsland, D., Larsen, J. P., Tandberg, E., & Laake, K. (2000) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2000.tb06891.x · Cited by 811 · see citing works

Spreading of pathology in neurodegenerative diseases: a focus on human studies

Brettschneider, J., Tredici, K. D., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3887 · Cited by 790 · see citing works

Short latency inhibition of human hand motor cortex by somatosensory input from the hand

Tokimura, H., Lazzaro, V. D., Tokimura, Y., Oliviero, A., Profice, P., Insola, A., Mazzone, P., Tonali, P., & Rothwell, J. C. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.t01-1-00503.x · Cited by 771 · see citing works

M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced Dyskinesia

Shen, W., Plotkin, J. L., Francardo, V., Ko, W. K. D., Xie, Z., Li, Q., Fieblinger, T., Wess, J., Neubig, R. R., Lindsley, C. W., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.10.039 · Cited by 713 · see citing works

Effects of Xanomeline, a Selective Muscarinic Receptor Agonist, on Cognitive Function and Behavioral Symptoms in Alzheimer Disease

Bodick, N. C., Offen, W., Levey, A. I., Cutler, N. R., Gauthier, S. G., Satlin, A., Shannon, H. E., Tollefson, G. D., Rasmussen, K., Bymaster, F. P., et al. (1997) · Archives of Neurology · doi:10.1001/archneur.1997.00550160091022 · Cited by 687 · see citing works

The thalamic reticular nucleus: structure, function and concept

Pinault, D. (2004) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.04.008 · Cited by 683 · see citing works

Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain

Selden, N. (1998) · Brain · doi:10.1093/brain/121.12.2249 · Cited by 657 · see citing works

Prefrontal Acetylcholine Release Controls Cue Detection on Multiple Timescales

Parikh, V., Kozak, R., Martinez, V., & Sarter, M. (2007) · Neuron · doi:10.1016/j.neuron.2007.08.025 · Cited by 623 · see citing works

Visual hallucinations in Lewy body disease relate to Lewy bodies in the temporal lobe

Harding, A., Broe, G. A., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf033 · Cited by 608 · see citing works

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

Compta, Y., Parkkinen, L., O’Sullivan, S. S., Vandrovcová, J., Holton, J. L., Collins, C., Lashley, T., Kallis, C., Williams, D. R., de Silva, R., et al. (2011) · Brain · doi:10.1093/brain/awr031 · Cited by 585 · see citing works

Selective Muscarinic Receptor Agonist Xanomeline as a Novel Treatment Approach for Schizophrenia

Shekhar, A., Potter, W. Z., Lightfoot, J., Lienemann, J., Dubé, S., Mallinckrodt, C. H., Bymaster, F. P., McKinzie, D. L., & Felder, C. C. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.06091591 · Cited by 563 · see citing works

A DCM for resting state fMRI

Friston, K. J., Kahan, J., Biswal, B., & Razi, A. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2013.12.009 · Cited by 553 · see citing works

Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: Observations based on the distribution of acetylcholinesterase and choline acetyltransferase

Mesulam, M. M., & Geula, C. (1988) · The Journal of Comparative Neurology · doi:10.1002/cne.902750205 · Cited by 520 · see citing works

Thalamic functions in distributed cognitive control

Halassa, M. M., & Kästner, S. (2017) · Nature Neuroscience · doi:10.1038/s41593-017-0020-1 · Cited by 513 · see citing works

Structural and functional diversity of native brain neuronal nicotinic receptors

Gotti, C., Clementi, F., Fornari, A., Gaimarri, A., Guiducci, S., Manfredi, I., Moretti, M., Pedrazzi, P., Pucci, L., & Zoli, M. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.05.024 · Cited by 469 · see citing works

Acetylcholine contributes through muscarinic receptors to attentional modulation in V1

Herrero, J. L., Roberts, M. J., Delicato, L. S., Gieselmann, M. A., Dayan, P., & Thiele, A. (2008) · Nature · doi:10.1038/nature07141 · Cited by 459 · see citing works

Representation of Non-Spatial and Spatial Information in the Lateral Entorhinal Cortex

Deshmukh, S. S., & Knierim, J. J. (2011) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2011.00069 · Cited by 454 · see citing works

Clinical correlates of selective pathology in the amygdala of patients with Parkinson’s disease

Harding, A. J., Stimson, E., Henderson, J. M., & Halliday, G. M. (2002) · Brain · doi:10.1093/brain/awf251 · Cited by 445 · see citing works

Cortical cholinergic inputs mediating arousal, attentional processing and dreaming: differential afferent regulation of the basal forebrain by telencephalic and brainstem afferents.

Sarter, M., & Bruno, J. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00487-x · Cited by 440 · see citing works

Hallucinations, REM sleep, and Parkinson’s disease

Arnulf, I., Bonnet, A.-M., Damier, P., Bejjani, B.-P. W., Seilhean, D., Derenne, J., & Agid, Y. (2000) · Neurology · doi:10.1212/wnl.55.2.281 · Cited by 439 · see citing works

Why people see things that are not there: A novel Perception and Attention Deficit model for recurrent complex visual hallucinations

Collerton, D., Perry, E. K., & McKeith, I. G. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05000130 · Cited by 437 · see citing works

Optogenetic activation of septal cholinergic neurons suppresses sharp wave ripples and enhances theta oscillations in the hippocampus

Vandecasteele, M., Varga, V., Berényi, A., Papp, E., Barthó, P., Venance, L., Freund, T. F., & Buzsáki, G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411233111 · Cited by 409 · see citing works

A 12-Year Population-Based Study of Psychosis in Parkinson Disease

Forsaa, E. B., Larsen, J. P., Wentzel‐Larsen, T., Goetz, C. G., Stebbins, G. T., Aarsland, D., & Alves, G. W. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.166 · Cited by 400 · see citing works

The pedunculopontine nucleus in Parkinson's disease

Zweig, R. M., Jankel, W. R., Hedreen, J. C., Mayeux, R. P., & Price, D. L. (1989) · Annals of Neurology · doi:10.1002/ana.410260106 · Cited by 388 · see citing works

A central role for the lateral prefrontal cortex in goal-directed and stimulus-driven attention

Asplund, C. L., Todd, J. J., Snyder, A. P., & Marois, R. (2010) · Nature Neuroscience · doi:10.1038/nn.2509 · Cited by 384 · see citing works

Mechanism of Deep Brain Stimulation

Chiken, S., & Nambu, A. (2015) · The Neuroscientist · doi:10.1177/1073858415581986 · Cited by 375 · see citing works

Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer’s and Parkinson’s disease

Liu, A. K. L., Chang, R. C., Pearce, R. K. B., & Gentleman, S. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1392-5 · Cited by 365 · see citing works

An improved neuroanatomical model of the default-mode network reconciles previous neuroimaging and neuropathological findings

Alves, P. N., Foulon, C., Karolis, V., Bzdok, D., Margulies, D. S., Volle, E., & Thiebaut de Schotten, M. (2019) · Communications Biology · doi:10.1038/s42003-019-0611-3 · Cited by 357 · see citing works

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

Klein, J. C., Eggers, C., Kalbe, E., Weisenbach, S., Hohmann, C., Vollmar, S., Baudrexel, S., Diederich, N. J., Heiß, W.-D., & Hilker, R. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d55f61 · Cited by 355 · see citing works

The psychosis spectrum in Parkinson disease

ffytche, D. H., Creese, B., Politis, M., Chaudhuri, K. R., Weintraub, D., Ballard, C., & Aarsland, D. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.200 · Cited by 355 · see citing works

Neuromodulation of Attention

Thiele, A., & Bellgrove, M. A. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.008 · Cited by 350 · see citing works

New evidence on the management of Lewy body dementia

Taylor, J.-P., McKeith, I. G., Burn, D. J., Boeve, B. F., Weintraub, D., Bamford, C., Allan, L. M., Thomas, A. J., & O'Brien, J. T. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(19)30153-x · Cited by 347 · see citing works

A Major External Source of Cholinergic Innervation of the Striatum and Nucleus Accumbens Originates in the Brainstem

Dautan, D., Huerta-Ocampo, I., Witten, I. B., Deisseroth, K. A., Bolam, J. P., Gerdjikov, T. V., & Mena‐Segovia, J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5071-13.2014 · Cited by 335 · see citing works

Free Energy, Precision and Learning: The Role of Cholinergic Neuromodulation

Moran, R. J., Campo, P., Symmonds, M., Stephan, K. E., Dolan, R. J., & Friston, K. J. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.4255-12.2013 · Cited by 312 · see citing works

Hallucinations in Parkinson disease

Diederich, N. J., Fénelon, G., Stebbins, G., & Goetz, C. G. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.62 · Cited by 312 · see citing works

Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease

Burn, D. J., Emre, M., McKeith, I. G., Deyn, P. P. D., Aarsland, D., Hsu, C., & Lane, R. M. (2006) · Movement Disorders · doi:10.1002/mds.21077 · Cited by 310 · see citing works

Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches

Bohnen, N. I., Yarnall, A. J., Weil, R. S., Moro, E., Moehle, M. S., Borghammer, P., Bédard, M., & Albin, R. L. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00377-x · Cited by 309 · see citing works

Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson’s disease

Hall, H., Reyes, S., Landeck, N., Bye, C. R., Leanza, G., Double, K. L., Thompson, L. H., Halliday, G. M., & Kirik, D. (2014) · Brain · doi:10.1093/brain/awu193 · Cited by 306 · see citing works

Optogenetic activation of cholinergic neurons in the PPT or LDT induces REM sleep

Van Dort, C. J., Zachs, D. P., Kenny, J. D., Zheng, S., Goldblum, R. R., Gelwan, N. A., Ramos, D. M., Nolan, M. A., Wang, K., Weng, F.-J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423136112 · Cited by 296 · see citing works

Repeated visual hallucinations in Parkinson's disease as disturbed external/internal perceptions: Focused review and a new integrative model

Diederich, N. J., Goetz, C. G., & Stebbins, G. T. (2004) · Movement Disorders · doi:10.1002/mds.20308 · Cited by 290 · see citing works

Acetylcholine and Hallucinations - Disease-Related Compared to Drug-Induced Alterations in Human Consciousness

Perry, E. K., & Perry, R. H. (1995) · Brain and Cognition · doi:10.1006/brcg.1995.1255 · Cited by 277 · see citing works

The parahippocampal gyrus links the default‐mode cortical network with the medial temporal lobe memory system

Ward, A. M., Schultz, A. P., Huijbers, W., Dijk, K. R. A. V., Hedden, T., & Sperling, R. A. (2013) · Human Brain Mapping · doi:10.1002/hbm.22234 · Cited by 271 · see citing works

Hippocampal sharp-wave ripples linked to visual episodic recollection in humans

Norman, Y., Yeagle, E. M., Khuvis, S., Harel, M., Mehta, A. D., & Malach, R. (2019) · Science · doi:10.1126/science.aax1030 · Cited by 270 · see citing works

Arousal and sleep circuits

Jones, B. E. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-019-0444-2 · Cited by 265 · see citing works

Attentional modulation of thalamic reticular neurons

McAlonan, K., Cavanaugh, J., & Wurtz, R. H. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5602-05.2006 · Cited by 261 · see citing works

Rethinking the Pedunculopontine Nucleus: From Cellular Organization to Function

Mena‐Segovia, J., & Bolam, J. P. (2017) · Neuron · doi:10.1016/j.neuron.2017.02.027 · Cited by 249 · see citing works

Linking pattern completion in the hippocampus to predictive coding in visual cortex

Hindy, N. C., Ng, F. Y., & Turk-Browne, N. B. (2016) · Nature Neuroscience · doi:10.1038/nn.4284 · Cited by 246 · see citing works

Nicotinic acetylcholine receptor-mediated calcium signaling in the nervous system

Shen, J., & Yakel, J. L. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.64 · Cited by 242 · see citing works

Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson's disease

Pacchetti, C., Manni, R., Zangaglia, R., Mancini, F., Marchioni, E., Tassorelli, C., Terzaghi, M., Ossola, M., Martignoni, E., Moglia, A., et al. (2005) · Movement Disorders · doi:10.1002/mds.20582 · Cited by 242 · see citing works

Topographical Organization of the Pedunculopontine Nucleus

Martinez‐Gonzalez, C., Bolam, J. P., & Mena‐Segovia, J. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00022 · Cited by 240 · see citing works

Minor hallucinations occur in drug‐naive Parkinson's disease patients, even from the premotor phase

Pagonabarraga, J., Martinez‐Horta, S., Fernández de Bobadilla, R., Pérez, J., Ribosa‐Nogué, R., Marín, J., Pascual‐Sedano, B., García, C., Gironell, A., & Kulisevsky, J. (2016) · Movement Disorders · doi:10.1002/mds.26432 · Cited by 236 · see citing works

Gateways of Ventral and Dorsal Streams in Mouse Visual Cortex

Wang, Q., Gao, E., & Burkhalter, A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3488-10.2011 · Cited by 232 · see citing works

Neurotransmission in Parkinson’s disease: beyond dopamine

Barone, P. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02900.x · Cited by 222 · see citing works

Prediction and memory: A predictive coding account

Barron, H. C., Auksztulewicz, R., & Friston, K. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101821 · Cited by 220 · see citing works

Stimulation of the nucleus basalis of Meynert increases acetylcholine release in the cerebral cortex in rats

Kurosawa, M., Sato, A., & Sato, Y. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90371-6 · Cited by 212 · see citing works

An acetylcholine-activated microcircuit drives temporal dynamics of cortical activity

Chen, N., Sugihara, H., & Sur, M. (2015) · Nature Neuroscience · doi:10.1038/nn.4002 · Cited by 210 · see citing works

Visual misperceptions and hallucinations in Parkinson's disease: Dysfunction of attentional control networks?

Shine, J. M., Halliday, G. M., Naismith, S. L., & Lewis, S. J. G. (2011) · Movement Disorders · doi:10.1002/mds.23896 · Cited by 205 · see citing works

Cerebral blood flow predicts differential neurotransmitter activity

Dukart, J., Holiga, Š., Chatham, C. H., Hawkins, P. C. T., Forsyth, A., McMillan, R. L., Myers, J., Lingford-Hughes, A. R., Nutt, D., Merlo‐Pich, E., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22444-0 · Cited by 203 · see citing works

Hallucinations and perceptual inference

Friston, K. J. (2005) · Behavioral and Brain Sciences · doi:10.1017/s0140525x05290131 · Cited by 196 · see citing works

Reality monitoring and visual hallucinations in Parkinson’s disease

Barnes, J., Boubert, L., Harris, J., Lee, A., & David, A. S. (2003) · Neuropsychologia · doi:10.1016/s0028-3932(02)00182-3 · Cited by 192 · see citing works

Cholinergic nucleus basalis neurons may influence the cortex via the thalamus

Levey, A. I., Hallanger, A. E., & Wainer, B. H. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90042-5 · Cited by 189 · see citing works

Coordinated Acetylcholine Release in Prefrontal Cortex and Hippocampus Is Associated with Arousal and Reward on Distinct Timescales

Ruivo, L. M. T.-G., Baker, K. L., Conway, M. W., Kinsley, P. J., Gilmour, G., Phillips, K. G., Isaac, J. T. R., Lowry, J. P., & Mellor, J. R. (2017) · Cell Reports · doi:10.1016/j.celrep.2016.12.085 · Cited by 175 · see citing works

Basal forebrain acetylcholine release during REM sleep is significantly greater than during waking

Vazquez, J. M., & Baghdoyan, H. A. (2001) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2001.280.2.r598 · Cited by 173 · see citing works

Localization of nicotinic receptor subunit mRNAs in monkey brain by in situ hybridization

Quik, M., Polonskaya, Y., Gillespie, A. J., Jakowec, M. W., Lloyd, G. K., & Langston, J. W. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000911)425:1 · Cited by 172 · see citing works

Hallucinations and sleep disorders in PD

Goetz, C. G., Wuu, J., Curgian, L. M., & Leurgans, S. E. (2005) · Neurology · doi:10.1212/01.wnl.0000148479.10865.fe · Cited by 171 · see citing works

Intravenous levodopa in hallucinating Parkinson's disease patients

Goetz, C. G., Pappert, E. J., Blasucci, L. M., Stebbins, G. T., Ling, Z. D., Nora, M. V., & Carvey, P. M. (1998) · Neurology · doi:10.1212/wnl.50.2.515 · Cited by 170 · see citing works

Constructing, Perceiving, and Maintaining Scenes: Hippocampal Activity and Connectivity

Zeidman, P., Mullally, S. L., & Maguire, E. A. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu266 · Cited by 169 · see citing works

Cortical hypometabolism and hypoperfusion in Parkinson’s disease is extensive: probably even at early disease stages

Borghammer, P., Chakravarty, M., Jonsdottir, K., Sato, N., Matsuda, H., Ito, K., Arahata, Y., Kato, T., & Gjedde, A. (2010) · Brain Structure and Function · doi:10.1007/s00429-010-0246-0 · Cited by 160 · see citing works

Reduced α4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease

Meyer, P., Strecker, K., Kendziorra, K., Becker, G., Hesse, S., Woelpl, D., Hensel, A., Patt, M., Sorger, D., Wegner, F., et al. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.106 · Cited by 158 · see citing works

Tricks of the mind: Visual hallucinations as disorders of attention

Shine, J. M., O’Callaghan, C., Halliday, G. M., & Lewis, S. J. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.004 · Cited by 157 · see citing works

Donepezil in the treatment of hallucinations and delusions in Parkinson’s disease

Fabbrini, G., Barbanti, P., Aurilia, C., Pauletti, C., Lenzi, G. L., & Meco, G. (2002) · Neurological Sciences · doi:10.1007/s100720200022 · Cited by 154 · see citing works

Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson’s disease with hallucinations

Goldman, J. G., Stebbins, G. T., Dinh, V., Bernard, B. A., Merkitch, D., deToledo‐Morrell, L., & Goetz, C. G. (2014) · Brain · doi:10.1093/brain/awt360 · Cited by 152 · see citing works

The Cholinergic Brain in Parkinson's Disease

Pasquini, J., Brooks, D. J., & Pavese, N. (2021) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.13319 · Cited by 149 · see citing works

Dementia and visual hallucinations associated with limbic pathology in Parkinson's disease

Kalaitzakis, M. E., Christian, L., Moran, L. B., Graeber, M. B., Pearce, R. K. B., & Gentleman, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.05.007 · Cited by 146 · see citing works

Spatiotemporally heterogeneous coordination of cholinergic and neocortical activity

Lohani, S., Moberly, A. H., Benisty, H., Landa, B., Jing, M., Li, Y., Higley, M. J., & Cardin, J. A. (2022) · Nature Neuroscience · doi:10.1038/s41593-022-01202-6 · Cited by 146 · see citing works

M1 Receptors Mediate Cholinergic Modulation of Excitability in Neocortical Pyramidal Neurons

Gulledge, A. T., Bucci, D. J., Zhang, S. S., Matsui, M., & Yeh, H. H. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.1366-09.2009 · Cited by 143 · see citing works

Cholinergic projections from the parabigeminal nucleus (Ch8) to the superior colliculus in the mouse: a combined analysis of horseradish peroxidase transport and choline acetyltransferase immunohistochemistry

Mufson, E. J., Martin, T. L., Mash, D. C., Wainer, B. H., & Mesulam, M. M. (1986) · Brain Research · doi:10.1016/0006-8993(86)91114-5 · Cited by 141 · see citing works

Bilateral Deep Brain Stimulation of the Nucleus Basalis of Meynert for Parkinson Disease Dementia

Gratwicke, J., Zrinzo, L. U., Kahan, J., Peters, A., Beigi, M., Akram, H., Hyam, J. A., Oswal, A., Day, B. L., Mancini, L., et al. (2017) · JAMA Neurology · doi:10.1001/jamaneurol.2017.3762 · Cited by 141 · see citing works

Hippocampal ripples and their coordinated dialogue with the default mode network during recent and remote recollection

Norman, Y., Raccah, O., Liu, S., Parvizi, J., & Malach, R. (2021) · Neuron · doi:10.1016/j.neuron.2021.06.020 · Cited by 140 · see citing works

Deletion of M ₁ Muscarinic Acetylcholine Receptors Increases Amyloid Pathology <i>In Vitro</i> and <i>In Vivo</i>

Davis, A. A., Fritz, J. J., Wess, J., Lah, J. J., & Levey, A. I. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.6393-09.2010 · Cited by 137 · see citing works

Regional cerebral blood flow in Parkinson disease with nonpsychotic visual hallucinations

Oishi, N., Udaka, F., Kameyama, M., Sawamoto, N., Hashikawa, K., & Fukuyama, H. (2005) · Neurology · doi:10.1212/01.wnl.0000187116.13370.e0 · Cited by 137 · see citing works

Targeting Muscarinic Acetylcholine Receptors for the Treatment of Psychiatric and Neurological Disorders

Moran, S. P., Maksymetz, J., & Conn, P. J. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.10.007 · Cited by 137 · see citing works

Muscarinic Signaling in the Brain

Thiele, A. (2013) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-062012-170433 · Cited by 136 · see citing works

Hippocampal head atrophy predominance in Parkinson’s disease with hallucinations and with dementia

Ibarretxe‐Bilbao, N., Ramírez‐Ruiz, B., Tolosa, E., Martı́, M. J., Valldeoriola, F., Bargalló, N., & Junqué, C. (2008) · Journal of Neurology · doi:10.1007/s00415-008-0885-8 · Cited by 134 · see citing works

Structural Brain Alterations Associated with Rapid Eye Movement Sleep Behavior Disorder in Parkinson’s Disease

Boucetta, S., Salimi, A., Dadar, M., Jones, B. E., Collins, D. L., & Dang‐Vu, T. T. (2016) · Scientific Reports · doi:10.1038/srep26782 · Cited by 134 · see citing works

The role of dysfunctional attentional control networks in visual misperceptions in Parkinson's disease

Shine, J. M., Halliday, G. M., Gilat, M., Matar, E., Bolitho, S., Carlos, M., Naismith, S. L., & Lewis, S. J. G. (2013) · Human Brain Mapping · doi:10.1002/hbm.22321 · Cited by 133 · see citing works

Differential progression of brain atrophy in Parkinson's disease with and without visual hallucinations

Ibarretxe‐Bilbao, N., Ramírez‐Ruiz, B., Junqué, C., Martí, M. J., Valldeoriola, F., Bargalló, N., Juanes, S., & Tolosa, E. (2009) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.179655 · Cited by 133 · see citing works

Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment

Grothe, M. J., Heinsen, H., Amaro, E., Grinberg, L. T., & Teipel, S. J. (2015) · Cerebral Cortex · doi:10.1093/cercor/bhv062 · Cited by 128 · see citing works

Altered Muscarinic and Nicotinic Receptor Densities in Cortical and Subcortical Brain Regions in Parkinson's Disease

Lange, K. W., Wells, F. R., Jenner, P. G., & MARSDEN, C. D. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05838.x · Cited by 125 · see citing works

Separate elements of episodic memory subserved by distinct hippocampal-prefrontal connections

Barker, G. R. I., Banks, P. J., Scott, H., Ralph, G. S., Mitrophanous, K. A., Wong, L.-F., Bashir, Z. I., Uney, J. B., & Warburton, E. C. (2017) · Nature Neuroscience · doi:10.1038/nn.4472 · Cited by 124 · see citing works

Metabolic Alterations in Patients With Parkinson Disease and Visual Hallucinations

Boecker, H., Ceballos-Baumann, A., Volk, D., Conrad, B., Förstl, H., & Häussermann, P. (2007) · Archives of Neurology · doi:10.1001/archneur.64.7.984 · Cited by 123 · see citing works

Nucleus basalis of Meynert neuronal activity during a delayed response task in monkey

Richardson, R. T., & DeLong, M. R. (1986) · Brain Research · doi:10.1016/0006-8993(86)91529-5 · Cited by 122 · see citing works

Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease

Manganelli, F., Vitale, C., Santangelo, G., Pisciotta, C., Iodice, R., Cozzolino, A., Dubbioso, R., Picillo, M., Barone, P., & Santoro, L. (2009) · Brain · doi:10.1093/brain/awp166 · Cited by 122 · see citing works

The pedunculopontine nucleus is related to visual hallucinations in Parkinson’s disease: preliminary results of a voxel-based morphometry study

Janzen, J., Ent, D. V. ‘., Lemstra, A. W., Berendse, H. W., Barkhof, F., & Foncke, E. M. J. (2011) · Journal of Neurology · doi:10.1007/s00415-011-6149-z · Cited by 120 · see citing works

Hallucinations in Parkinson's disease: A follow‐up study

de Maindreville, A. D., Fénelon, G., & Mahieux, F. (2004) · Movement Disorders · doi:10.1002/mds.20263 · Cited by 119 · see citing works

What is the link between hallucinations, dreams, and hypnagogic–hypnopompic experiences?

Waters, F., Blom, J. D., Dang-Vu, T. T., Cheyne, A. J., Alderson-Day, B., Woodruff, P., & Collerton, D. (2016) · Schizophrenia Bulletin · doi:10.1093/schbul/sbw076 · Cited by 119 · see citing works

Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation.

Wallace, W., Ahlers, S. T., Gotlib, J. R., Bragin, V., Sugar, J., Gluck, R., SHEA, P. A., Davis, K. L., & Haroutunian, V. H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.18.8712 · Cited by 118 · see citing works

Selective deficits in attentional performance on the 5-choice serial reaction time task following pedunculopontine tegmental nucleus lesions

Inglis, W. L., Olmstead, M. C., & Robbins, T. W. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00181-4 · Cited by 112 · see citing works

Forebrain Cholinergic Signaling: Wired and Phasic, Not Tonic, and Causing Behavior

Sarter, M. F., & Lustig, C. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1305-19.2019 · Cited by 110 · see citing works

Structural and functional neuroimaging in patients with Parkinson's disease and visual hallucinations: A critical review

Lenka, A., Jhunjhunwala, K. R., Saini, J., & Pal, P. K. (2015) · Parkinsonism &amp; Related Disorders · doi:10.1016/j.parkreldis.2015.04.005 · Cited by 106 · see citing works

Abnormal connectivity between the default mode and the visual system underlies the manifestation of visual hallucinations in Parkinson’s disease: a task-based fMRI study

Shine, J. M., Muller, A. J., O’Callaghan, C., Hornberger, M., Halliday, G. M., & Lewis, S. J. (2015) · npj Parkinson's Disease · doi:10.1038/npjparkd.2015.3 · Cited by 106 · see citing works

Visual hallucination in Parkinson's disease with FDG PET

Nagano‐Saito, A., Washimi, Y., Arahata, Y., Iwai, K., Kawatsu, S., Ito, K., Nakamura, A., Abe, Y., Yamada, T., Kato, T., et al. (2004) · Movement Disorders · doi:10.1002/mds.20129 · Cited by 105 · see citing works

Cognitive Changes in Parkinson’s Disease Patients with Visual Hallucinations

Ramírez‐Ruiz, B., Junqué, C., Martı́, M. J., Valldeoriola, F., & TOLOSA, E. S. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100850 · Cited by 104 · see citing works

Positive allosteric modulator of alpha 7 nicotinic-acetylcholine receptors, PNU-120596 augments the effects of donepezil on learning and memory in aged rodents and non-human primates

Callahan, P. M., Hutchings, E. J., Kille, N. J., Chapman, J., & Terry, A. V. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.019 · Cited by 102 · see citing works

The integrative role of the pedunculopontine nucleus in human gait

Lau, B., Welter, M., Belaïd, H., Fernández-Vidal, S., Bardinet, É., Grabli, D., & Karachi, C. (2015) · Brain · doi:10.1093/brain/awv047 · Cited by 101 · see citing works

Widespread decrease of nicotinic acetylcholine receptors in Parkinson's disease

Fujita, M., Ichise, M., Zoghbi, S. S., Liow, J., Ghose, S., Vines, D. C., Sangare, J., Lu, J., Cropley, V., Iida, H., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20688 · Cited by 100 · see citing works

Assignment of muscarinic receptor subtypes mediating G-protein modulation of Ca 2+ channels by using knockout mice

Shapiro, M. S., Loose, M. D., Hamilton, S. E., Nathanson, N. M., Gomeza, J., Wess, J., & Hille, B. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.19.10899 · Cited by 99 · see citing works

Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations

Papapetropoulos, S., McCorquodale, D. S., Gonzalez, J., Jean-Gilles, L., & Mash, D. C. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.10.005 · Cited by 98 · see citing works

Effects of scopolamine on MEG spectral power and coherence in elderly subjects

Osipova, D. V., Ahveninen, J., Kaakkola, S., Jääskeläinen, I. P., Huttunen, J., & Pekkonen, E. (2003) · Clinical Neurophysiology · doi:10.1016/s1388-2457(03)00165-2 · Cited by 97 · see citing works

Frequency-dependent increase in cortical acetylcholine release evoked by stimulation of the nucleus basalis magnocellularis in the rat

Rasmusson, D. D., Clow, K. A., & Szerb, J. C. (1992) · Brain Research · doi:10.1016/0006-8993(92)91041-c · Cited by 96 · see citing works

Cortical Lewy bodies and Aβ burden are associated with prevalence and timing of dementia in Lewy body diseases

Ruffmann, C., Calboli, F. C. F., Bravi, I., Gveric, D. O., Curry, L. K., de Smith, A. J., Pavlou, S., Buxton, J. L., Blakemore, A. I. F., Takousis, P., et al. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12294 · Cited by 96 · see citing works

Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease

van der Zee, S., Müller, M. L. T. M., Kanel, P., van Laar, T., & Bohnen, N. I. (2020) · Movement Disorders · doi:10.1002/mds.28360 · Cited by 96 · see citing works

Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative

Ffytche, D. H., Pereira, J. B., Ballard, C. G., Chaudhuri, К. R., Weintraub, D. A., & Aarsland, D. (2017) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2016-314832 · Cited by 94 · see citing works

Acetylcholine is released in the basolateral amygdala in response to predictors of reward and enhances the learning of cue-reward contingency

Crouse, R. B., Kim, K. K. O., Batchelor, H. M., Girardi, E., Kamaletdinova, R., Chan, J., Rajebhosale, P., Pittenger, S. T., Role, L. W., Talmage, D. A., et al. (2020) · eLife · doi:10.7554/elife.57335 · Cited by 92 · see citing works

Hallucinations and sleep-wake cycle in PD

Manni, R., Pacchetti, C., Terzaghi, M., Sartori, I., Mancini, F., & Nappi, G. (2002) · Neurology · doi:10.1212/01.wnl.0000038351.32678.4a · Cited by 91 · see citing works

T he pedunculopontine tegmental nucleus— A functional hypothesis from the comparative literature

Gut, N. K., & Winn, P. (2016) · Movement Disorders · doi:10.1002/mds.26556 · Cited by 89 · see citing works

Hallucinations and sleep disorders in PD

Goetz, C. G., Ouyang, B., Negron, A., & Stebbins, G. T. (2010) · Neurology · doi:10.1212/wnl.0b013e3181fd6158 · Cited by 88 · see citing works

Role of nitric oxide and acetylcholine in neocortical hyperemia elicited by basal forebrain stimulation: Evidence for an involvement of endothelial nitric oxide

Zhang, F., Xu, S., & Iadecola, C. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00302-y · Cited by 87 · see citing works

Rational Engineering of Enzyme Allosteric Regulation through Sequence Evolution Analysis

Yang, J.-S., Seo, S. W., Jang, S., Jung, G. Y., & Kim, S. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002612 · Cited by 87 · see citing works

Visual hallucinations in Parkinson's disease: Theoretical models

Muller, A. J., Shine, J. M., Halliday, G. M., & Lewis, S. J. G. (2014) · Movement Disorders · doi:10.1002/mds.26004 · Cited by 85 · see citing works

Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease

Shin, S., Lee, J. E., Hong, J. Y., Sunwoo, M.-K., Sohn, Y. H., & Lee, P. H. (2012) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-303391 · Cited by 83 · see citing works

Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations

Khundakar, A. A., Hanson, P. S., Erskine, D., Lax, N. Z., Roscamp, J., Karyka, E., Tsefou, E., Singh, P., Cockell, S., Gribben, A., et al. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0334-3 · Cited by 83 · see citing works

Understanding visual hallucinations: A new synthesis

Collerton, D., Barnes, J., Diederich, N. J., Dudley, R., ffytche, D., Friston, K., Goetz, C. G., Goldman, J. G., Jardri, R., Kulisevsky, J., et al. (2023) · Neuroscience &amp; Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105208 · Cited by 83 · see citing works

Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson’s disease

Borghammer, P., Cumming, P. D., Aanerud, J., & GJEDDE, A. H. (2008) · NeuroImage · doi:10.1016/j.neuroimage.2008.07.042 · Cited by 82 · see citing works

Organisational and neuromodulatory underpinnings of structural-functional connectivity decoupling in patients with Parkinson’s disease

Zarkali, A., McColgan, P., Leyland, L., Lees, A. J., Rees, G. E., & Weil, R. S. (2021) · Communications Biology · doi:10.1038/s42003-020-01622-9 · Cited by 82 · see citing works

Selectively driving cholinergic fibers optically in the thalamic reticular nucleus promotes sleep

Ni, K.-M., Hou, X., Yang, C.-H., Dong, P., Li, Y., Zhang, Y., Jiang, P., Berg, D. K., Duan, S., & Li, X. (2016) · eLife · doi:10.7554/elife.10382 · Cited by 81 · see citing works

Role of the locus coeruleus and basal forebrain in arousal and attention

Maness, E. B., Burk, J. A., McKenna, J. T., Schiffino, F. L., Strecker, R. E., & McCoy, J. G. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.07.014 · Cited by 81 · see citing works

Hallucinations, somatic‐functional disorders of PD‐DLB as expressions of thalamic dysfunction

ONOFRJ, M. C., Espay, A. J., Bonanni, L., Pizzi, S. D., & Sensi, S. L. (2019) · Movement Disorders · doi:10.1002/mds.27781 · Cited by 79 · see citing works

Basal forebrain contributes to default mode network regulation

Nair, J., Klaassen, A.-L., Arato, J., Vyssotski, A. L., Harvey, M., & Rainer, G. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712431115 · Cited by 77 · see citing works

Noradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing

Orlando, I. F., Shine, J. M., Robbins, T. W., Rowe, J. B., & O’Callaghan, C. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105167 · Cited by 77 · see citing works

Intermittent Stimulation of the Nucleus Basalis of Meynert Improves Working Memory in Adult Monkeys

Liu, R., Crawford, J., Callahan, P. M., Terry, A. V., Constantinidis, C., & Blake, D. T. (2017) · Current Biology · doi:10.1016/j.cub.2017.07.021 · Cited by 76 · see citing works

Disruption of the default mode network and its intrinsic functional connectivity underlies minor hallucinations in Parkinson's disease

Bejr‐Kasem, H., Pagonabarraga, J., Martínez‐Horta, S., Sampedro, F., Marín‐Lahoz, J., Horta‐Barba, A., Aracil‐Bolaños, I., Pérez‐Pérez, J., Boti, M. A., Campolongo, A., et al. (2018) · Movement Disorders · doi:10.1002/mds.27557 · Cited by 76 · see citing works

Regional vulnerability of hippocampal subfields and memory deficits in Parkinson's disease

Pereira, J. B., Junqué, C., David Bartrés-faz, A., Ramírez‐Ruiz, B., Martı́, M. J., & TOLOSA, E. S. (2013) · Hippocampus · doi:10.1002/hipo.22131 · Cited by 74 · see citing works

Hypoperfusion of the visual pathway in parkinsonian patients with visual hallucinations

Matsui, H., Nishinaka, K., Oda, M., Hara, N., Komatsu, K., Kubori, T., & Udaka, F. (2006) · Movement Disorders · doi:10.1002/mds.21140 · Cited by 73 · see citing works

Network effects of deep brain stimulation

Alhourani, A., McDowell, M. M., Randazzo, M. J., Wozny, T. A., Kondylis, E. D., Lipski, W. J., Beck, S., Karp, J. F., Ghuman, A. S., & Richardson, R. M. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00275.2015 · Cited by 72 · see citing works

Neuromodulation of the mind-wandering brain state: the interaction between neuromodulatory tone, sharp wave-ripples and spontaneous thought

O’Callaghan, C., Walpola, I. C., & Shine, J. M. (2020) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2019.0699 · Cited by 72 · see citing works

Differences in Response to Muscarinic Activation Between First and Higher Order Thalamic Relays

Varela, C., & Sherman, S. M. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00578.2007 · Cited by 71 · see citing works

What do phasic cholinergic signals do?

Sarter, M. F., Lustig, C., Berry, A. S., Gritton, H. J., Howe, W. M., & Parikh, V. (2016) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2016.02.008 · Cited by 71 · see citing works

Neuroimaging in Parkinson’s disease dementia: connecting the dots

Weil, R. S., Hsu, J. K., Darby, R. R., Soussand, L., & Fox, M. D. (2019) · Brain Communications · doi:10.1093/braincomms/fcz006 · Cited by 71 · see citing works

Diverse Spatiotemporal Scales of Cholinergic Signaling in the Neocortex

Disney, A. A., & Higley, M. J. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.1306-19.2019 · Cited by 71 · see citing works

Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease: A Meta-analysis

d’Angremont, E., Begemann, M. J. H., van Laar, T., & Sommer, I. E. C. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.1835 · Cited by 71 · see citing works

Functional evaluation of central cholinergic circuits in patients with Parkinson’s disease and REM sleep behavior disorder: a TMS study

Nardone, R., Bergmann, J., Brigo, F., Christova, M., Kunz, A. B., Seidl, M., Tezzon, F., Trinka, E., & Golaszewski, S. M. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0888-6 · Cited by 69 · see citing works

Molecular Imaging of the Cholinergic System in Parkinson's Disease

Bohnen, N. I., Kanel, P., & Müller, M. L. T. M. (2018) · International review of neurobiology · doi:10.1016/bs.irn.2018.07.027 · Cited by 69 · see citing works

Intralaminar nuclei of the thalamus in Lewy body diseases

Brooks, D., & Halliday, G. M. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.08.014 · Cited by 66 · see citing works

Involvement of a Subpopulation of Neuronal M4Muscarinic Acetylcholine Receptors in the Antipsychotic-like Effects of the M1/M4Preferring Muscarinic Receptor Agonist Xanomeline

Dencker, D., Wörtwein, G., Weikop, P., Jeon, J., Thomsen, M., Sager, T. N., Mørk, A., Woldbye, D. P. D., Wess, J., & Fink‐Jensen, A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0370-11.2011 · Cited by 65 · see citing works

Classics in Chemical Neuroscience: Xanomeline

Bender, A. M., Jones, C. K., & Lindsley, C. W. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00001 · Cited by 65 · see citing works

Increased weighting on prior knowledge in Lewy body-associated visual hallucinations

Zarkali, A., Adams, R. A., Psarras, S., Leyland, L., Rees, G. E., & Weil, R. S. (2019) · Brain Communications · doi:10.1093/braincomms/fcz007 · Cited by 65 · see citing works

White Matter Damage in the Cholinergic System Contributes to Cognitive Impairment in Subcortical Vascular Cognitive Impairment, No Dementia

Liu, Q., Zhu, Z., Teipel, S. J., Yang, J., Xing, Y., Tang, Y., & Jia, J. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00047 · Cited by 64 · see citing works

Cholinergic double duty: cue detection and attentional control

Sarter, M., & Lustig, C. (2019) · Current Opinion in Psychology · doi:10.1016/j.copsyc.2018.12.026 · Cited by 64 · see citing works

Bilateral nucleus basalis of Meynert deep brain stimulation for dementia with Lewy bodies: A randomised clinical trial

Gratwicke, J., Zrinzo, L. U., Kahan, J., Peters, A., Brechany, U., McNichol, A., Beigi, M., Akram, H., Hyam, J. A., Oswal, A., et al. (2020) · Brain stimulation · doi:10.1016/j.brs.2020.04.010 · Cited by 64 · see citing works

Baseline symptoms and basal forebrain volume predict future psychosis in early Parkinson disease

Barrett, M. J., Blair, J. C., Sperling, S. A., Smolkin, M. E., & Druzgal, T. J. (2018) · Neurology · doi:10.1212/wnl.0000000000005421 · Cited by 63 · see citing works

Multimodal MRI of the hippocampus in Parkinson’s disease with visual hallucinations

Yao, N., Cheung, C., Pang, S. Y.-Y., Chang, R. S., Lau, K. K., John Suckling, A., Yu, K., Mak, H. K., Chua, S. E., Ho, S., et al. (2014) · Brain Structure and Function · doi:10.1007/s00429-014-0907-5 · Cited by 62 · see citing works

Synaptic Proteins and Choline Acetyltransferase Loss in Visual Cortex in Dementia With Lewy Bodies

Mukaetova‐Ladinska, E. B., Andras, A., Milne, J., Abdel‐All, Z., Borr, I., Jaros, E., Perry, R. H., Honer, W. G., Cleghorn, A., Doherty, J., et al. (2012) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e31827c5710 · Cited by 62 · see citing works

Brain atrophy in Parkinson’s disease with polysomnography-confirmed REM sleep behavior disorder

Rahayel, S., Gaubert, M., Postuma, R. B., Montplaisir, J. Y., Carrier, J., Monchi, O., Rémillard-Pelchat, D., Bourgouin, P.-A., Panisset, M., Chouinard, S., et al. (2019) · SLEEP · doi:10.1093/sleep/zsz062 · Cited by 62 · see citing works

Muscarinic acetylcholine receptors act in synergy to facilitate learning and memoryPreprint

Leaderbrand, K., Chen, H. J., Corcoran, K. A., Guedea, A. L., Jovasevic, V., Wess, J., & Radulović, J. (2016) · Learning & Memory · doi:10.1101/lm.043133.116 · Cited by 58 · see citing works

Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations

Jacobson, S. A., Morshed, T., Dugger, B. N., Beach, T. G., Hentz, J. G., Adler, C. H., Shill, H. A., Sabbagh, M. N., Belden, C. M., Sue, L. I., et al. (2014) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.06.018 · Cited by 57 · see citing works

Differences in network controllability and regional gene expression underlie hallucinations in Parkinson’s disease

Zarkali, A., McColgan, P., Ryten, M., Reynolds, R. H., Leyland, L., Lees, A. J., Rees, G. E., & Weil, R. S. (2020) · Brain · doi:10.1093/brain/awaa270 · Cited by 57 · see citing works

The Pharmacology of Visual Hallucinations in Synucleinopathies

Russo, M., Carrarini, C., Dono, F., Rispoli, M. G., Pietro, M. D., Stefano, V. D., Ferri, L., Bonanni, L., Sensi, S. L., & ONOFRJ, M. C. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01379 · Cited by 56 · see citing works

Neurobiological Impact of Nicotinic Acetylcholine Receptor Agonists: An Activation Likelihood Estimation Meta-Analysis of Pharmacologic Neuroimaging Studies

Sutherland, M. T., Ray, K. L., Riedel, M. C., Yanes, J. A., Stein, E. A., & Laird, A. R. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.021 · Cited by 55 · see citing works

Investigating visual misperceptions in Parkinson's disease: A novel behavioral paradigm

Shine, J. M., Halliday, G. M., Carlos, M., Naismith, S. L., & Lewis, S. J. G. (2012) · Movement Disorders · doi:10.1002/mds.24900 · Cited by 53 · see citing works

Pedunculopontine Cholinergic Cell Loss in Hallucinating Parkinson Disease Patients but Not in Dementia With Lewy Bodies Patients

Hepp, D. H., Ruiter, A. M., Galis, Y., Voorn, P., Rozemüller, A. J. M., Berendse, H. W., Foncke, E. M. J., & van de Berg, W. D. J. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000014 · Cited by 52 · see citing works

Structural and molecular cholinergic imaging markers of cognitive decline in Parkinson’s disease

Schumacher, J., Kanel, P., Dyrba, M., Storch, A., Bohnen, N. I., Teipel, S. J., & Grothe, M. J. (2023) · Brain · doi:10.1093/brain/awad226 · Cited by 50 · see citing works

Regulation of cerebral cortical blood flow by the basal forebrain cholinergic fibers and aging

Sato, A., Sato, Y., & Uchida, S. (2002) · Autonomic Neuroscience · doi:10.1016/s1566-0702(01)00367-8 · Cited by 49 · see citing works

Hallucinations and sleep disturbances in Parkinson’s disease

Kulisevsky, J., & Gerschcovich, E. R. (2004) · Neurology · doi:10.1212/wnl.63.8_suppl_3.s28 · Cited by 48 · see citing works

Quantification of nicotinic acetylcholine receptors in Parkinson's disease with 123I-5IA SPECT

Oishi, N., Hashikawa, K., Yoshida, H., Ishizu, K., Ueda, M., Kawashima, H., Saji, H., & Fukuyama, H. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.02.014 · Cited by 48 · see citing works

Cholinergic and perfusion brain networks in Parkinson disease dementia

Colloby, S. J., McKeith, I. G., Burn, D. J., Wyper, D. J., O'Brien, J. T., & Taylor, J. (2016) · Neurology · doi:10.1212/wnl.0000000000002839 · Cited by 48 · see citing works

Effect of Rivastigmine on Behavioral and Psychiatric Symptoms of Parkinson’s Disease Dementia

Oh, Y., Kim, J., & Lee, P. H. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.15041 · Cited by 47 · see citing works

Cell type specific sequestration of choline acetyltransferase and tyrosine hydroxylase within Lewy bodies

Dugger, B. N., & Dickson, D. W. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0739-1 · Cited by 47 · see citing works

Thalamic cholinergic innervation makes a specific bottom-up contribution to signal detection: Evidence from Parkinson’s disease patients with defined cholinergic losses

Kim, K., Müller, M. L. T. M., Bohnen, N. I., Sarter, M. F., & Lustig, C. (2017) · NeuroImage · doi:10.1016/j.neuroimage.2017.02.006 · Cited by 46 · see citing works

Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson’s disease patients with visual hallucinations

Hepp, D. H., Foncke, E. M. J., Berendse, H. W., Wassenaar, T. M., Dubbelink, K. T. E. O., Groenewegen, H. J., van de Berg, W. D. J., & Schoonheim, M. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-10146-y · Cited by 45 · see citing works

Well-maintained responses of acetylcholine release and blood flow in the cerebral cortex to focal electrical stimulation of the nucleus basalis of Meynert in aged rats

Kurosawa, M., Sato, A., & Sato, Y. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90684-8 · Cited by 43 · see citing works

Nicotinic acetylcholine receptors control encoding and retrieval of associative recognition memory through plasticity in the medial prefrontal cortex

Sabec, M. H., Wonnacott, S., Warburton, E. C., & Bashir, Z. I. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.016 · Cited by 42 · see citing works

Mapping brain structural differences and neuroreceptor correlates in Parkinson’s disease visual hallucinations

Vignando, M., ffytche, D., Lewis, S. J. G., Lee, P. H., Chung, S. J., Weil, R. S., Hu, M. T., Mackay, C. E., Griffanti, L., Pins, D., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28087-0 · Cited by 42 · see citing works

Structural connections between the noradrenergic and cholinergic system shape the dynamics of functional brain networks

Taylor, N. L., D’Souza, A., Munn, B., Lv, J., Záborszky, L., Müller, E. J., Wainstein, G., Calamante, F., & Shine, J. M. (2022) · NeuroImage · doi:10.1016/j.neuroimage.2022.119455 · Cited by 42 · see citing works

Mind-wandering in Parkinson's disease hallucinations reflects primary visual and default network coupling

Walpola, I. C., Muller, A. J., Hall, J. M., Andrews‐Hanna, J. R., Irish, M., Lewis, S. J. G., Shine, J. M., & O’Callaghan, C. (2020) · Cortex · doi:10.1016/j.cortex.2019.12.023 · Cited by 41 · see citing works

Mapping Cholinergic Synaptic Loss in Parkinson’s Disease: An [18F]FEOBV PET Case-Control Study

Horsager, J., Okkels, N., Hansen, A. K., Damholdt, M. F., Andersen, K. H., Fedorova, T. D., Munk, O. L., Danielsen, E. H., Pavese, N., Brooks, D. J., et al. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223489 · Cited by 41 · see citing works

Recent Advances in the Discovery of Nicotinic Acetylcholine Receptor Allosteric Modulators

Manetti, D., Dei, S., Arias, H. R., Braconi, L., Gabellini, A., Teodori, E., & Romanelli, M. N. (2023) · Molecules · doi:10.3390/molecules28031270 · Cited by 41 · see citing works

Rhythmic interactions between the mediodorsal thalamus and prefrontal cortex precede human visual perception

Griffiths, B., Zaehle, T., Repplinger, S., Schmitt, F. C., Voges, J., Hanslmayr, S., & Staudigl, T. (2022) · Nature Communications · doi:10.1038/s41467-022-31407-z · Cited by 40 · see citing works

The structural connectivity mapping of the intralaminar thalamic nuclei

Kumar, V., Scheffler, K., & Grodd, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-38967-0 · Cited by 39 · see citing works

Hallucinations and REM sleep behaviour disorder in Parkinson’s disease: Dream imagery intrusions and other hypotheses

Manni, R., Terzaghi, M., Ratti, P., Repetto, A., Zangaglia, R., & Pacchetti, C. (2010) · Consciousness and Cognition · doi:10.1016/j.concog.2010.10.009 · Cited by 38 · see citing works

Functional connectivity increase in the default-mode network of patients with Alzheimer׳s disease after long-term treatment with Galantamine

Blautzik, J., Keeser, D., Paolini, M., Kirsch, V., Berman, A., Coates, U., Reiser, M. F., Teipel, S. J., & Meindl, T. (2015) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2015.12.006 · Cited by 38 · see citing works

Loss of cholinergic innervation differentially affects eNOS-mediated blood flow, drainage of Aβ and cerebral amyloid angiopathy in the cortex and hippocampus of adult mice

Nizari, S., Wells, J. A., Carare, R. O., Romero, I. A., & Hawkes, C. A. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01108-z · Cited by 38 · see citing works

Changes in both top-down and bottom-up effective connectivity drive visual hallucinations in Parkinson’s disease

Thomas, G. E. C., Zeidman, P., Sultana, T., Zarkali, A., Razi, A., & Weil, R. S. (2022) · Brain Communications · doi:10.1093/braincomms/fcac329 · Cited by 38 · see citing works

Neuromodulatory role of acetylcholine in visually-induced cortical activation: Behavioral and neuroanatomical correlates

Dotigny, F., Amor, A. Y. B., Burke, M., & Vaucher, E. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.04.030 · Cited by 37 · see citing works

Progression of regional cortical cholinergic denervation in Parkinson’s disease

Bohnen, N. I., Roytman, S., Kanel, P., Müller, M. L. T. M., Scott, P. J. H., Frey, K. A., Albin, R. L., & Koeppe, R. A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac320 · Cited by 37 · see citing works

Visual Hallucinations and Cognitive Impairment in Parkinson's Disease

Park, H. K., Kim, J. S., Im, K. C., Kim, M. J., Lee, J., Lee, M. C., Kim, J., & Chung, S. J. (2013) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100014888 · Cited by 36 · see citing works

Redefining Non-Motor Symptoms in Parkinson’s Disease

Peña-Zelayeta, L., Delgado-Minjares, K. M., Villegas-Rojas, M. M., León‐Arcia, K., Santiago-Balmaseda, A., Andrade-Guerrero, J., Pérez-Segura, I., Ortega‐Robles, E., Soto-Rojas, L. O., & Arias-Carrión, Ó. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15050172 · Cited by 76 · see citing works

Neuropsychiatric disorders in Parkinson’s disease

Heim, B., & Djamshidian, A. (2025) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864251356062 · Cited by 24 · see citing works

Region-specific variations in the cerebrovasculature underlie disease progression in Parkinson's disease

Dik, D., Halliday, G. M., Sytnyk, V., & Shepherd, C. E. (2025) · Brain · doi:10.1093/brain/awaf305 · Cited by 8 · see citing works

Functional Magnetic Resonance Imaging (f MRI) Signatures of Progression and Phenoconversion in Prodromal Synucleinopathies

Churchill, L., Ignatavicius, A., Konuri, A., Anderson, J., Taylor, N. L., Lewis, S. J. G., & Matar, E. (2025) · Movement Disorders · doi:10.1002/mds.70025 · Cited by 7 · see citing works

Mapping the neural and molecular basis underlying fatigue in Parkinson’s disease

Yang, F., Shen, J.-Y., Sun, Z.-Q., Tan, L., Yang, R., Zhu, L., Mo, Y., Shao, H., Hou, J., Sun, Z., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01216-4 · Cited by 4 · see citing works

Core Clinical Features Associated With Survival in Patients With Dementia With Lewy Bodies

McCarter, S. J., Ferman, T. J., Grant, K. M., Aakre, J. A., Knopman, D. S., Graff‐Radford, N. R., Forsberg, L. K., Fields, J. A., Day, G. S., Miyagawa, T., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000214197 · Cited by 4 · see citing works

The challenges with the identification of Parkinson’s disease subtypes

Rigon, L., Popławska-Domaszewicz, K., Metta, V., Fogliano, C. A., Nasi, M. L., Sauerbier, A., Dafsari, H., Leta, V., Falup‐Pecurariu, C., Odin, P., et al. (2025) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2611250 · Cited by 3 · see citing works

Basal Forebrain Volume Predicts Disease Conversion in Prodromal Synucleinopathy

Churchill, L., Konuri, A., Ignatavicius, A., Anderson, J., Lewis, S. J. G., & Matar, E. (2025) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.70242 · Cited by 4 · see citing works

Combined Dysfunction of the Amygdala and Nucleus Basalis Underlies Visual Hallucinations in Parkinson's Disease

Ignatavicius, A., Churchill, L., Anderson, J., Konuri, A., O’Callaghan, C., Lewis, S. J. G., & Matar, E. (2025) · Movement Disorders · doi:10.1002/mds.70011 · Cited by 3 · see citing works

Association of the number of minor hallucinations and well-structured visual hallucinations in Parkinson’s disease

Zhang, H., Zhao, Y., Chen, Y., Feng, Y., Shen, B., Dong, S., Zhu, J., Jiang, X., Li, D., Chen, Y., et al. (2025) · npj Parkinson s Disease · doi:10.1038/s41531-025-01106-9 · Cited by 3 · see citing works

Imposter in the brain: aetiological, clinical and neuroimaging characteristics of Capgras syndrome

Hiroyuki, W., Whitwell, J. L., Bhaskaran, J. G., Lowe, V. J., & Josephs, K. A. (2025) · Brain · doi:10.1093/brain/awaf378 · Cited by 2 · see citing works

Comparing phenotypic features between Parkinson’s disease dementia and dementia with Lewy bodies

Gunawardana, C. W., Burke, P. G. R., Ignatavicius, A., Matar, E., & Lewis, S. J. G. (2026) · Journal of Neurology · doi:10.1007/s00415-026-13649-9 · Cited by 2 · see citing works

Sleep-like slow waves during wakefulness uncover a malignant form of Parkinson’s diseasePreprint

Bernasconi, F., Andrillon, T., Farah, J. C., Arnulf, I., Schwartz, S., Potheegadoo, J., Martínez‐Horta, S., Pagonabarraga, J., Kulisevsky, J., & Blanke, O. (2025) · medRxiv · doi:10.1101/2025.08.29.25334276 · Cited by 2 · see citing works

Cholinergic neurotransmission underlying visual hallucinations in Parkinson's disease: Integration of multimodal evidence and translational approaches

Liu, J., Yu, D., Liu, Y., Yong, Y., Wang, Z., Fan, P., & Yang, X. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107316 · Cited by 1 · see citing works

Non-invasive brain stimulation for treating cognitive and neuropsychiatric non-motor symptoms in Parkinson’s disease and atypical parkinsonism: a systematic review and meta-analysis of randomized controlled trials

Mantovani, E., Bertoncello, E., Filippetti, M., Picelli, A., Tinazzi, M., & Tamburin, S. (2026) · Journal of Neural Transmission · doi:10.1007/s00702-026-03127-x · Cited by 1 · see citing works

Responsible AI in healthcare: Mitigating hallucinations and enhancing multimodal fusion - based reasoning in medical imaging

Iqbal, S., Zhong, X., Khan, M. A., Wu, Z., Almujally, N. A., Liu, W., Cambria, E., & Hussain, A. (2026) · Information Fusion · doi:10.1016/j.inffus.2026.104483 · Cited by 3 · see citing works

Data-driven trajectories of atrophy explain clinical heterogeneity across Lewy body diseases

Konuri, A., Leal, G. C., Zebarjadi, N., Habich, A., Castellanos-Perilla, N., González, M. C., Taylor, J., Firbank, M., Alcolea, D. A., Bejanin, A., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106400 · Cited by 1 · see citing works

Abnormal intrinsic brain functional network dynamics in amnestic mild cognitive impairment

Li, L., Wu, J., Zheng, M., Xue, X., Ma, J., Hua, X., & Xu, J. (2025) · Brain Conflux · doi:10.71321/bgaxq397 · Cited by 1 · see citing works

Deviations in effective connectivity explain different hallucination subtypes in Parkinson's disease psychosis

Vignando, M., Ffytche, D., Mazibuko, N., Palma, G., Bhat, A., Montagnese, M., Dave, S., Tai, Y. F., Batzu, L., Leta, V., et al. (2026) · Nature Mental Health · doi:10.1038/s44220-026-00669-7

Disrupted functional brain network associated with presence of hallucinations in Parkinson’s disease

Montagnese, M., Mehta, M. A., Ffytche, D. H., Firbank, M., Lawson, R. A., Taylor, J., Bullmore, E. T., & Morgan, S. E. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf185

Platelet-derived growth factor is increased with cognitive fluctuations and hallucinations in Lewy Body disease

Youssef, P., Chua, M., Andersson, L. I., Galper, J., Gunawardana, C. W., Matar, E., Halliday, G. M., Lewis, S. J. G., & Dzamko, N. L. (2025) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2025.108094

Hallucinations in Parkinson’s Disease: What They Really Look Like and How They Affect the Quality of Life

Necpál, J., Grofik, M., Patarák, M., Jeleňová, B., Bebjaková, V., & Baranová, L. (2025) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/s44411-025-00414-z

Gray Matter Volume Loss in Parkinson's Disease Psychosis and Cannabinoid Receptor Gene Expression in the Brain

Pisani, S., Váša, F., Velayudhan, L., & Bhattacharyya, S. (2026) · Movement Disorders · doi:10.1002/mds.70222

Physicochemical balancing facilitates fast cyclic immunolabeling in centimeter-scale FFPE tissuesPreprint

Lin, Y., Huang, C.-Y., Chen, Y.-H., Chen, Y., Ko, P., Hsu, H., Tung, Y., Chen, Y.-F., Chen, Y.-F., Chiang, A.-S., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.09.710440

Rivastigmine for Behavioural Symptoms in Parkinson's Disease: Evidence and Open Questions

Luca, A. (2026) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.70049

Regional brain dysfunction patterns associated with rapid eye movement sleep behavior disorder and visual hallucinations in Parkinson’s disease: a resting-state fMRI study with exploratory ROI-based factorial analysis

She, L., Xiong, W., Cai, H. R., Zhou, L. H., Li, Z., & Pan, Y. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1858348

Exploring the therapeutic potential of Astragalin in Parkinson’s disease: a network pharmacology approach

Liu, H., Shen, W., Zhou, H., Gao, Y., & Li, X. (2026) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000005442

Isolated visual hallucinations as the first sign of lacunar infarcts: A late-onset psychosis mimic

Unni, N., Longkumer, I., & Bhosale, M. S. (2026) · Journal of Medical Society · doi:10.4103/jms.jms_45_26

Inflammation and neuropsychiatric symptoms in Parkinson's disease: a genetic association

Gonçalves, A. R., Mendes, A., Damásio, J., Vila‐Chã, N., Boleixa, D., Santos, C., Leal, B., & Cavaco, S. (2026) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2026.1877657

Reduced volume of neuromodulatory brainstem nuclei is associated with early hallucination-related vulnerability in Parkinson’s disease

Monopoli, G., Tomaiuolo, F., Sestieri, C., Punzi, M., Marino, S., Gambi, F., Perrucci, M. G., Ferretti, A., Sensi, S. L., & Pizzi, S. D. (2026) · Brain Communications · doi:10.1093/braincomms/fcag357

Non-motor symptoms of parkinson's disease and their pharmacological management

El-Jaafary, S. I. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-27702-3.00019-4

Ocular Function Illuminates A Multisystem Rhythm Centered Framework for Parkinson’s Disease Pathophysiology

(2026) · Psychiatry and Behavioral Sciences · doi:10.5455/pbs.20260305045651

Cholinergic neurotransmission underlying visual hallucinations in Parkinson's disease: Integration of multimodal evidence and translational approaches

Liu, J., Yu, D., Liu, Y., Yong, Y., Wang, Z., Fan, P., & Yang, X. (2026) · Neurobiology of Disease · doi:10.1016/j.nbd.2026.107316 · Cited by 1 · see citing works

Visual hallucinations in Parkinson disease are associated with cholinergic dysfunction

Jones, N. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.122

Cholinergic deficiency in Parkinson’s disease patients with visual hallucinations

d’Angremont, E., van der Zee, S., Slingerland, S., Slomp, A. C., de Vries, E. F. J., van Laar, T., & Sommer, I. E. (2024) · Brain · doi:10.1093/brain/awae186 · Cited by 22 · see citing works

Cholinergic Integrity And Visual Hallucinations In Parkinson Disease (S18.004)

Bohnen, N. I., Müller, M. L. T. M., Kotagal, V., Albin, R. L., & Frey, K. A. (2014) · Neurology · doi:10.1212/wnl.82.10_supplement.s18.004

Possible Contribution of Altered Cholinergic Activity in the Visual Cortex in Visual Hallucinations in Parkinson’s Disease

Sinclair, L. I., Brenton, J., Liu, A. K. L., MacLachlan, R. A., Gentleman, S., & Love, S. (2021) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.21040103 · Cited by 10 · see citing works